Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15003 | 668 | 39.0 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
254 | 19163 | PROBIOTICS//LACTIC ACID BACTERIA//LACTOBACILLUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LACTOCOCCUS LACTIS | Author keyword | 26 | 16% | 23% | 152 |
2 | UNITE RECH LAITIE GENET PL | Address | 10 | 31% | 4% | 26 |
3 | GEM PARTICLES | Author keyword | 6 | 100% | 1% | 4 |
4 | GENET PL | Address | 5 | 50% | 1% | 7 |
5 | COMMENSAL PROBIOT HOST INTERACT | Address | 5 | 35% | 2% | 11 |
6 | NISIN CONTROLLED EXPRESSION SYSTEM | Author keyword | 4 | 67% | 1% | 4 |
7 | CORTECS VACCINE DISCOVERY | Address | 4 | 75% | 0% | 3 |
8 | RECOMBINANT LACTIC ACID BACTERIA | Author keyword | 4 | 75% | 0% | 3 |
9 | TETANOS | Address | 3 | 100% | 0% | 3 |
10 | UNITE IMMUNOALLERGIE ALIMENTAIRE | Address | 3 | 40% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TOXIN FRAGMENT C | 43 | 43% | 12% | 77 |
2 | MUCOSAL DELIVERY | 24 | 52% | 5% | 32 |
3 | E7 ANTIGEN | 21 | 85% | 2% | 11 |
4 | RECOMBINANT LACTOCOCCUS LACTIS | 20 | 66% | 3% | 19 |
5 | CONTROLLED GENE EXPRESSION | 20 | 28% | 9% | 60 |
6 | ACID BACTERIA | 16 | 11% | 21% | 141 |
7 | SUBSP LACTIS | 7 | 13% | 8% | 53 |
8 | SYSTEM NICE | 7 | 64% | 1% | 7 |
9 | ORAL COLONIZATION | 7 | 32% | 3% | 18 |
10 | DNA VACCINE VECTOR | 6 | 71% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria | 2008 | 194 | 95 | 59% |
Engineering lactococci and lactobacilli for human health | 2013 | 17 | 32 | 50% |
Mucosal Vaccination and Therapy with Genetically Modified Lactic Acid Bacteria | 2011 | 33 | 110 | 61% |
Lactococcus lactis-based vaccines from laboratory bench to human use: An overview | 2012 | 14 | 65 | 65% |
Lactococcus lactis as a live vector: Heterologous protein production and DNA delivery systems | 2011 | 23 | 96 | 58% |
Exploiting the peptidoglycan-binding motif, LysM, for medical and industrial applications | 2014 | 4 | 82 | 44% |
10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis | 2005 | 203 | 107 | 30% |
Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production | 2005 | 82 | 76 | 61% |
Lactococcus lactis as a Cell Factory for Delivery of Therapeutic Proteins | 2010 | 19 | 106 | 49% |
Bacterial expression systems for recombinant protein production: E. coli and beyond | 2012 | 38 | 43 | 16% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNITE RECH LAITIE GENET PL | 10 | 31% | 3.9% | 26 |
2 | GENET PL | 5 | 50% | 1.0% | 7 |
3 | COMMENSAL PROBIOT HOST INTERACT | 5 | 35% | 1.6% | 11 |
4 | CORTECS VACCINE DISCOVERY | 4 | 75% | 0.4% | 3 |
5 | TETANOS | 3 | 100% | 0.4% | 3 |
6 | UNITE IMMUNOALLERGIE ALIMENTAIRE | 3 | 40% | 0.9% | 6 |
7 | BIOTECHNOL DRUG DELIVERY | 3 | 42% | 0.7% | 5 |
8 | UNITE ECOL PHYSIOL SYST DIGESTIF | 3 | 17% | 2.1% | 14 |
9 | UNITE ECOL PHYSIOL SYST DIGEST | 2 | 15% | 2.1% | 14 |
10 | BENEFICIAL MICROORGANISMS FUNCT FOODS HLTH | 2 | 67% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228864 | FELIX HERELLE REFERENCE BACTERIAL VIRUSES//PHAGE RESISTANCE//LACTOCOCCUS LACTIS |
2 | 0.0000157206 | CELL SURFACE DISPLAY//SURFACE DISPLAY//CELL SURFACE ENGINEERING |
3 | 0.0000145012 | CITRATE PERMEASE//DIACETYL//ALPHA ACETOLACTATE |
4 | 0.0000092775 | BILE SALT HYDROLASE//BILE TOLERANCE//PROBIOTIC |
5 | 0.0000091984 | PROBIOTICS//ESCHERICHIA COLI NISSLE 1917//LACTOBACILLUS GG |
6 | 0.0000063164 | SORTASE//SORTASE A//SRTA |
7 | 0.0000060685 | CHOLERA TOXIN//HEAT LABILE ENTEROTOXIN//RECOMBINANT CHOLERA TOXIN B SUBUNIT RCTB |
8 | 0.0000056026 | ENDOLYSIN//ENZYBIOTIC//HOLIN |
9 | 0.0000055912 | BACTOFECTION//BACTERIAL THERAPY//SALMONELLA TYPHIMURIUM A1 R |
10 | 0.0000051256 | LANTIBIOTIC//LANTIBIOTICS//GALLIDERMIN |